Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis

Cancer Genetics and Cytogenetics

Volumn 201, Issue 1, 2010, Pages 15-23

  Yusenko, Maria V ^a   Nagy, Anetta ^a   Kovacs, Gyula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CHROMATID EXCHANGE; CHROMOSOME 12Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 6Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 6; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FAMILIAL CANCER; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENE NUMBER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; DNA PRIMERS; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 77954651076     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.04.018     Document Type: Article

References (41)

1. Cohen A.J., Li F.P., Berg S., Marchetto D.J., Tsai S., Jacobs S.C., et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979, 301:592-595.
2. Kovacs G., Hoene E. Loss of der(3) in renal cell carcinoma cells of a patient with constitutional t(3;12). Hum Genet 1988, 78:148-150.
3. Kovacs G., Brusa P., DeRiese W. Tissue specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal cell carcinomas. Int J Cancer 1989, 43:422-427.
4. Kovacs G., Szücs S., De Riese W., Baumgärtel H. Specific chromosome aberration in human renal cell carcinoma. Int J Cancer 1987, 40:171-178.
5. Kovacs G., Erlandsson R., Boldog F., Ingvarsson S., Müller-Brechlin R., Klein G., et al. Consistent 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A 1988, 85:591-595.
6. Kovacs G., Emanuel A., Neumann H.P.H., Kung H. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease. Genes Chromosomes Cancer 1991, 3:256-262.
7. Kovacs G., Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 1989, 49:651-659.
8. Kovacs G., Kung H.F. Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci U S A 1991, 88:194-198.
9. Zbar B., Brauch H., Talmadge C., Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987, 327:721-724.
10. Chudek J., Wilhelm M., Bugert P., Herbers J., Kovacs G. Detailed microsatellite analysis of chromosome 3p region in nonpapillary renal cell carcinomas. Int J Cancer 1997, 73:225-229.
11. Shridhar V., Rivard S., Shridhar R., Mullins C., Bostick L., Sakr W., et al. A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas. Oncogene 1996, 12:1931-1939.
12. Daigo Y., Nishiwaki T., Kawasoe T., Tamari M., Tsuchiya E., Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 1999, 59:1966-1972.
13. Morrissey C., Martinez A., Zatyka M., Agathanggelou A., Honorio S., Astuti D., et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 2001, 61:7277-7281.
14. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260:1317-1320.
15. Gnarra J.R., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994, 7:85-90.
16. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994, 91:9700-9704.
17. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597.
18. Gemmill R.M., West J.D., Boldog F., Tanaka N., Robinson L.J., Smith D.I., et al. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci U S A 1998, 95:9572-9577.
19. Thiagalingam S., Lisitsyn N.A., Hamaguchi M., Wigler M.H., Willson J.K., Markowitz S.D., et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996, 56:2936-2939.
20. Bugert P., Wilhelm M., Kovacs G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer 1997, 20:9-15.
21. Kanayama H., Lui W.O., Takahashi M., Naroda T., Kedra D., Wong F.K., et al. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma. J Med Genet 2001, 38:165-170.
22. Chen J., Lui W.-O., Vos M.D., Clark G.J., Takahashi M., Schoumans J., et al. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 2003, 4:405-413.
23. Druck T., Podolski J., Byrski T., Wyrwicz L., Zajaczek S., Kata G., et al. The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J Hum Genet 2001, 46:583-589.
24. Koolen M.I., van der Meyden A.P., Bodmer D., Eleveld M., van der Looij E., Brunner H., et al. A familial case of renal cell carcinoma and t(2;3) chromosome translocation. Kidney Int 1998, 53:273-275.
25. Bodmer D., Eleveld M., Kater-Baats E., Janssen B., Weterman M., Schoenmakers E., et al. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21). Hum Mol Genet 2002, 11:641-649.
26. Bodmer D., Schepens M., Eleveld M.J., Schoenmakers E.F., Geurts van Kessel A. Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAP1 fusion transcripts in a case of familial cell cancer and t(2;3)(q35;q21). Genes Chromosomes Cancer 2003, 38:107-116.
27. Bonne A., Vreede L., Kuiper R.P., Bodmer D., Jansen C., Eleveld M., et al. Mapping of constitutional translocation breakpoints in renal cell cancer patients: identification of KCNIP4 as a candidate gene. Cancer Genet Cytogenet 2007, 179:11-18.
28. Eleveld M.J., Bodmer D., Merkx G., Siepman A., Sprenger S.H., Weterman M.A., et al. Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q12;q15). Genes Chromosomes Cancer 2001, 31:23-32.
29. Foster R.E., Abdulrahman M., Morris M.R., Prigmore E., Gribble S., Ng B., et al. Characterization of a 3;6 translocation associated with renal cell carcinoma. Genes Chromosomes Cancer 2007, 46:311-317.
30. Rodríguez-Perales S., Meléndez B., Gribble S.M., Valle L., Carter N.P., Santamaría I., et al. Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement. Hum Mol Genet 2004, 13:983-990.
31. Valle L., Cascón A., Melchor L., Otero I., Rodríguez-Perales S., Sánchez L., et al. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family. Eur J Hum Genet 2005, 13:570-578.
32. Meléndez B., Rodríguez-Perales S., Martínez-Delgado B., Otero I., Robledo M., Martínez-Ramírez A., et al. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1). Hum Genet 2003, 112:178-185.
33. Kuiper R.P., Vreede L., Venkatachalam R., Ricketts C., Kamping E., Verwiel E., et al. The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer. Cancer Genet Cytogenet 2009, 195:105-111.
34. Fujita Y., Shirataki H., Sakisaka T., Asakura T., Ohya T., Kotani H., et al. Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process. Neuron 1998, 20:905-915.
35. Wilhelm M., Bugert P., Kenck C., Staehler G., Kovacs G. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinoma: a breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res 1995, 55:5383-5385.
36. Bugert P., Kenck C., Wilhelm M., Kovacs G. Refining a proximal breakpoint cluster at chromosome 3p11.2 in nonpapillary renal cell carcinomas. Int J Cancer 1996, 68:723-726.
37. Sükösd F., Kuroda N., Beothe T., Kaur A., Kovacs G. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 2003, 63:455-457.
38. Kovacs A., Kovacs G. Parenchymal abnormalities associated with papillary renal cell tumors: a morphologic study. J Urol Pathol 1993, 1:301-312.
39. Hollingsworth J.M., Miller D.C., Daignault S., Hollenbeck B.K. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006, 98:1331-1334.
40. Bodmer D., van der Hurk W., van Groningen J.J.M., Eleveld M.J., Martens G.J.M., Weterman M.A.J., et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet 2002, 11:2489-2498.
41. Mandriota S.J., Turner K.J., Davies D.R., Murray P.G., Morgan N.V., Sowter H.M., et al. HIF activation identified early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 2002, 1:459-468.